Acura Pharmaceuticals (ACUR) Income Statement
Acura Pharmaceuticals Income Statement
Last quarter (Q4 2021), Acura Pharmaceuticals's total revenue was $36.00K, a decrease of 94.41% from the same quarter last year. In Q4, Acura Pharmaceuticals's net income was $29.00K. See Acura Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 21 | Mar 21 | Dec 19 | Jun 19 | Dec 17 |
|---|---|---|---|---|---|
| $ 1.56M | $ 3.57M | $ 2.66M | $ 410.00K | $ 2.97M | |
| $ 352.00K | $ 3.57M | $ 2.65M | $ 408.24K | $ 2.84M | |
| $ 1.25M | $ 4.33M | $ 3.38M | $ 4.33M | $ 8.06M | |
| Depreciation and Amortization | $ 90.00K | $ 125.00K | $ 273.00K | $ 280.00K | $ 294.00K |
| $ -589.00K | $ -633.00K | $ -3.04M | $ -3.17M | $ -4.93M | |
| $ -1.21M | $ -758.00K | $ -725.00K | $ -3.92M | $ -5.22M | |
| $ 335.00K | $ -450.00K | $ -3.05M | $ 73.00K | $ -592.00K | |
| $ -879.00K | $ -1.21M | $ -3.77M | $ -3.84M | $ -5.82M | |
| $ -879.00K | $ -1.21M | $ -3.77M | $ -3.84M | $ -5.68M | |
| Per Share Metrics | |||||
| Basic EPS | $ -0.02 | $ -0.04 | $ -0.14 | $ -0.18 | $ -0.36 |
| Diluted EPS | $ -0.02 | $ -0.04 | $ -0.14 | $ -0.18 | $ -0.36 |
| Weighted Average Shares Outstanding | 43.95M | 30.20M | 26.72M | 21.15M | 15.90M |
| Weighted Average Shares Outstanding (Diluted) | 56.80M | 32.32M | 26.72M | 21.15M | 15.90M |
Currency in USD
